Related Experiment Video
Updated: May 13, 2026

Correction of Presbyopia by Monocular Bi-Aspheric Ablation Profile
Published on: September 20, 2024
Assessing the Visual and Refractive Outcomes of PRESBYOND Laser Blended Vision Treatment in Myopic and Hyperopic
Ricko Wai Leung Wong1,2, Courtney Beggs3,4, Catherine Marks5,4
1University of Notre Dame, Perth, Australia.
Purpose:
To evaluate the 6-month refractive and visual outcomes following PRESBYOND Laser Blended Vision (Carl Zeiss Meditec) treatment using non-linear aspheric micro-anisometropia laser in situ keratomileusis (LASIK) for the correction of myopic and hyperopic presbyopia.
Methods:
This was a retrospective, non-comparative study of 125 consecutive patients with a mean age of 53 ± 6 years (range: 42 to 70 years) who underwent LASIK-induced micro-anisometropia using the MEL 90 excimer laser and VISUMAX 800 femtosecond laser (Carl Zeiss Meditec AG). Preoperative and postoperative assessments of visual acuity and refractive error were conducted over a 6-month period. The target refraction was plano for the dominant eyes and between -1.00 and -1.75 diopters (D) for non-dominant eyes.
Results:
A total of 250 eyes (76 myopic and 174 hyperopic) were analyzed. Mean postoperative spherical equivalent refraction was -0.03 ± 0.24 D (myopic) and -0.03 ± 0.34 D (hyper-opic) for distance eyes and -1.51 ± 0.34 D (myopic) and -1.61 ± 0.34 D (hyperopic) for near eyes. Mean binocular UNVA was +0.08 ± 0.02 logarithm of the minimum angle of resolution (logMAR) (both myopic and hyperopic). Mean binocular UDVA was -0.05 ± 0.05 logMAR (myopic) and -0.06 ± 0.06 logMAR (hyperopic). Treatment demonstrated high refractive predictability and stability. A total of 94.4% (myopic and hyperopic) reported improved visual function and reduced spectacle dependence after initial treatment. The re-treatment rate was 5.3% in the myopic group and 12.6% in the hyperopic group. After re-treatment, 100% satisfaction was achieved in the hyperopic group and 98.8% in the myopic group.
Conclusions:
PRESBYOND laser treatment effectively improves both distance and near visual acuity in patients with presbyopia, with predictable refractive outcomes and high patient satisfaction. The non-linear aspheric micro-anisometropia protocol resulted in safe and effective visual outcomes in patients with both hyperopic and myopic presbyopia.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
